Skip to main content

Table 4 Outcomes

From: Influence of Staphylococcus aureus on Outcomes after Valvular Surgery for Infective Endocarditis

Outcomes Before PS Matching After PS Matching
  SA
(n = 85)
NSA
(n = 238)
OR (95% CI) p-Value SA
(n = 64)
NSA (n = 64) OR (95% CI) p-Value
30-day
 Composite 40 (47.1) 91 (38.2) 1.44 (0.87–2.37) 0.160 30 (46.9) 29 (45.3) 1.06 (0.54–2.10) 0.860
 Mortality 8 (9.4) 19 (8.0) 1.20 (0.50–2.85) 0.680 6 (9.4) 5 (7.8) 1.20 (0.37–3.93) 0.760
 Stroke 12 (14.3) 29 (12.2) 1.20 (0.58–2.48) 0.620 9 (14.1) 9 (14.1) 1.00 (0.38–2.66) 1.000
 Embolic Events 18 (21.4) 34 (14.3) 1.64 (0.87–3.09) 0.130 13 (20.3) 11 (17.2) 1.18 (0.53–2.64) 0.680
 Development of ARF 24 (28.6) 43 (18.1) 1.81 (1.02–3.23) 0.043 18 (28.1) 16 (25.0) 1.22 (0.51–2.95) 0.660
1 year
 Composite 48 (56.5) 104 (43.7) 1.67 (1.01–2.75) 0.044 37 (57.8) 30 (46.8) 1.70 (0.78–3.71) 0.180
 Mortality 17 (20.0) 34 (14.3) 1.50 (0.79–2.86) 0.220 13 (20.3) 9 (14.1) 1.57 (0.61–4.05) 0.350
 Stroke 16 (19.1) 32 (13.5) 1.51 (0.78–2.93) 0.220 12 (18.7) 9 (14.1) 1.43 (0.54–3.75) 0.470
 Embolic Events 22 (26.2) 37 (15.6) 1.93 (1.06–3.51) 0.032 16 (25.0) 13 (20.3) 1.27 (0.58–2.80) 0.550
 Development of ARF 28 (33.3) 51 (21.4) 1.83 (1.06–3.18) 0.031 22 (34.4) 18 (28.1) 1.40 (0.62–3.15) 0.420
  1. ARF Acute renal failure